UnitedHealth Group (NYSE:UNH) Stock Breaks Below 50 Day Moving Average – Time to Sell?

Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $391.42 and traded as low as $387.14. UnitedHealth Group shares last traded at $389.4550, with a volume of 8,035,896 shares trading hands.

Key Headlines Impacting UnitedHealth Group

Here are a few of the latest headlines about UNH:

  • Positive Sentiment: UnitedHealth appointed longtime healthcare executive Madeline S. Bell to its board, a move that may focus investor attention on governance and long-term capital allocation. Read article
  • Negative Sentiment: CMS has proposed wider Medicare Advantage audits under the CRUSH rule. The proposal could apply findings from payment year 2018 more broadly and recover an estimated $9 billion annually in overpayments, raising potential financial and regulatory risks for insurers including UnitedHealth. The measure is proposed, not final. Read article
  • Negative Sentiment: Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, while coverage also cited a Senate breakup bill. The prospect of structural changes adds policy uncertainty for UnitedHealth and contributed to selling pressure. Read article

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Weiss Ratings raised UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Raymond James Financial reaffirmed an “outperform” rating and set a $450.00 target price on shares of UnitedHealth Group in a report on Thursday, October 15th. DA Davidson set a $512.00 price target on UnitedHealth Group in a research report on Tuesday, July 21st. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research report on Friday, October 9th. Finally, JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a report on Friday, October 16th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $463.93.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Down 5.5%

The firm has a market cap of $348.96 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51. The stock’s 50 day moving average is $391.42 and its 200 day moving average is $366.73. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same period last year, the company posted $2.59 EPS. The firm’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its stake in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp raised its holdings in shares of UnitedHealth Group by 0.7% during the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after acquiring an additional 301,081 shares during the period. Bank of New York Mellon Corp lifted its position in shares of UnitedHealth Group by 6.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock worth $4,436,923,000 after purchasing an additional 583,536 shares during the period. Finally, Fisher Asset Management LLC grew its position in UnitedHealth Group by 19.2% during the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock worth $3,975,343,000 after purchasing an additional 1,747,368 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Recommended Stories

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.